Dyadic International (DYAI US)

Analysis

Health Care • United States

Dyadic International, Inc. is a global biotechnology company. The Company focuses on improving and applying the proprietary C1 expression system to help drug developers and manufacturers bring biologic drugs to market. Dyadic International focuses on drugs that will improve access and cost to patients as well as save lives.

Refresh

Company Presentation • 30 Jun 2026 19:00

Corporate presentation

Company Presentation • 19 May 2026 19:00

Investor presentation

Company Presentation • 30 Mar 2026 19:00

Investor presentation

Company Presentation • 14 Aug 2025 04:00

Investor Presentation

No more presentations

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00